Connect with licensed Nebraska telehealth providers offering semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro and Zepbound. Delivered free to your door. Free online doctor consultation.
Find GLP-1 ProvidersSkip the clinic. Complete a quick assessment, get approved by a licensed Nebraska physician, and have your prescription delivered.
See Prices — Free VisitThree simple steps to get GLP-1 medication delivered to your door
Answer a few quick questions about your health and weight loss goals. Takes less than 5 minutes.
A licensed Nebraska physician reviews your case and, if you qualify, prescribes the right GLP-1 protocol.
Your GLP-1 medication arrives at your Alvo address with free, discreet shipping.
Choose the GLP-1 option that fits your goals and budget
Most affordable GLP-1 option. Same active ingredient as Ozempic and Wegovy, prepared by licensed 503A/503B pharmacies. No insurance required — transparent monthly pricing.
More affordable tirzepatide. Same molecule as Mounjaro and Zepbound ($1,000+/month brand-name) with the greatest weight loss potential, at a fraction of brand-name pricing.
FDA-approved semaglutide. Insurance may cover for diabetes (Ozempic) or weight loss (Wegovy). With Novo Nordisk savings card, cost can drop to $25-$50/month.
FDA-approved tirzepatide. Lilly savings card can reduce cost by up to $573/month for commercially insured patients. Best results when combined with lifestyle changes.
Clinical outcomes from GLP-1 patients at 12 months
Multiple payment and savings options available in Alvo
Coverage for Ozempic, Wegovy, Mounjaro, or Zepbound varies widely by plan. Insurance may cover brand-name GLP-1 in some cases, depending on your plan. Our program needs no insurance: one all-inclusive price, no hidden fees.
Compounded semaglutide and tirzepatide are cash-pay: one flat monthly price, all doses included, free shipping, and no insurance required.
Compounded GLP-1 medications are the most affordable option for cash-pay patients. Free online doctor consultation for semaglutide, compounded versions contain the same active ingredients as brand-name.
Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Mounjaro, Zepbound) offer savings cards that can reduce brand-name costs dramatically for commercially insured patients.
Low-income patients may qualify for free or reduced-cost GLP-1 medication through Novo Nordisk's Patient Assistance Program or Lilly Cares. Eligibility is income-based.
Real patients, real transformations with GLP-1 medication
Everything you need to know about GLP-1 medication in Alvo
Alvo residents now have direct access to the full spectrum of GLP-1 weight loss medications through licensed Nebraska telehealth providers. With a population of approximately 123 residents and an adult obesity rate of 37.1%, Alvo is part of a nationwide shift toward accessible, evidence-based weight management. GLP-1 medications — including semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and Zepbound — are now available to qualifying adults throughout the Alvo metro area with no in-person visits required.
The two leading GLP-1 classes are semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound). Semaglutide activates one gut hormone receptor and produces 15-17% average body weight loss over 68 weeks. Tirzepatide activates two receptors (GLP-1 and GIP), producing up to 22.5% average weight loss at 72 weeks — the most powerful GLP-1 therapy approved today. Your Alvo provider will help you choose based on your health profile, weight loss goals, and budget.
Alvo patients can choose between brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) at $900-$1,350/month and more affordable compounded alternatives, with your final cost determined during your free online consultation. Compounded versions are prepared by 503A/503B licensed compounding pharmacies regulated by the Nebraska State Board of Pharmacy and the FDA, and contain the same active pharmaceutical ingredients as brand-name products. Compounding provides Alvo patients with a cash-pay option during shortages and for those without insurance coverage.
To qualify for GLP-1 weight loss medication in Alvo, patients generally need a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnea. Your Alvo provider will evaluate your medical history, current medications, and weight loss goals during the online assessment to determine eligibility and match you with the appropriate GLP-1 medication and starting dose.
Insurance coverage for GLP-1 weight loss medication in Nebraska varies significantly by plan. Many Blue Cross Blue Shield, UnitedHealthcare, Aetna, and Cigna plans cover Ozempic and Mounjaro for diabetic patients and Wegovy or Zepbound for weight management with prior authorization. Medicare Part D generally covers Ozempic and Mounjaro for diabetes but not Wegovy or Zepbound for weight loss. Our Alvo team can verify your benefits and submit prior authorization requests on your behalf to maximize coverage.
Common side effects of GLP-1 medications include nausea, diarrhea, decreased appetite, vomiting, constipation, and mild injection-site reactions — most resolve within the first 4 weeks as your body adjusts. Serious but rare risks include pancreatitis, gallbladder issues, and thyroid concerns. GLP-1 medications should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your Alvo physician will discuss the complete safety profile and start you on a low dose that titrates up gradually.
Starting GLP-1 weight loss treatment in Alvo takes just minutes. Complete a free 5-minute online assessment, a licensed Nebraska physician reviews your answers, and if you qualify you receive your prescription. Medication ships directly to your Alvo home with free, discreet shipping in temperature-controlled packaging with all supplies (needles, syringes, alcohol wipes) included. No in-person visits, no insurance hassles, no waiting rooms — just a seamless path to proven weight loss results.
Telehealth available across Nebraska and surrounding regions
GLP-1 telehealth available throughout Nebraska
Choose telehealth GLP-1 treatment with no insurance needed. Your licensed Nebraska physician will review your answers and, if you qualify, write your prescription.
See Prices — Free Visit